U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06775106) titled 'Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections' on Aug. 27, 2024.
Brief Summary: This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
Study Start Date: Nov. 30, 2024
Study Type: OBSERVATIONAL
Condition:
Pulmonary Disease
Critical Illness
Intervention:
OTHER: There is no intervention in this observational study
No direct intervention will be done to patients eligible for the study. There will be a shunt pl...